WHO ICTRP trial
Evaluation of topically applied cyclosporin in plaque psoriasis
CTRI/2025/02/080739 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/02/080739 |
|---|---|
| Public title | Evaluation of topically applied cyclosporin in plaque psoriasis |
| Scientific title | Dermal and systemic pharmacokinetics of topical cyclosporin in chronic plaque psoriasis - nil |
| Primary sponsor | Dr Ashish Kakkar |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: L400- Psoriasis vulgaris |
| Interventions | Intervention1: Topical formulation of cyclosporine: Standard amount of topical formulation will be applied once daily over healthy skin or lesion area in psoriasis patients (up to 2 weeks in patients) Control Intervention1: NA: NA |
| Registration date | Feb 18, 2025 |
| Target size | 84 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: